tradingkey.logo
tradingkey.logo
Pesquisar

Bone Biologics Corp

BBLG
Adicionar à lista de desejos
1.420USD
+0.020+1.43%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
2.55MValor de mercado
PerdaP/L TTM

Mais detalhes de Bone Biologics Corp Empresa

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Informações de Bone Biologics Corp

Código da empresaBBLG
Nome da EmpresaBone Biologics Corp
Data de listagemNov 27, 2015
CEOFrelick (Jeffrey)
Número de funcionários2
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 27
Endereço2 Burlington Woods Dr Ste 100
CidadeBURLINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01803-4551
Telefone17815524452
Sitehttps://www.bonebiologics.com/
Código da empresaBBLG
Data de listagemNov 27, 2015
CEOFrelick (Jeffrey)

Executivos da empresa Bone Biologics Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Bone Biologics Corp?

Os cinco principais acionistas de Bone Biologics Corp são: Mr. Jeffrey Frelick

Quantas instituições possuem ações da Bone Biologics Corp (BBLG)?

Em 2026Q1, 17 instituições possuíam ações da Bone Biologics Corp, com valor de mercado aproximado de 58.41K, representando 3.25% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 22009.00.